Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Cancer-killing Cells Controlled by Epigenetic… >
Cancer-killing Cells Controlled by Epigenetic Process, New Study Shows

Published: September 24, 2013.
By University of Southern California - Health Sciences
http://uscnews.usc.edu/archives/health/

Natural killer (NK) cells in the human body can kill and contain viruses and cancerous tumors, and a new study from the University of Southern California (USC) describes for the first time how those cells can be manipulated by epigenetics. The discovery, detailed in the Proceedings of the National Academy of Sciences, paves the way for developing more effective cancer drugs.

"Natural killer cells are very attractive targets for immunotherapy because they are able to kill tumor cells," said Si-Yi Chen, M.D., Ph.D., a faculty member of the USC Norris Comprehensive Cancer Center and senior author of the study. "While scientists all around the world are working on developing new drugs using NK cells, none of the drugs in development focuses on epigenetic regulation of the cells. Our study describes how an epigenetic process involving the enzyme MYSM1 plays a critical role in the development of natural killer cells."

Epigenetics involve biochemical changes in the body that directly affect DNA, turning some genes on and turning others off. MYSM1 is an enzyme in the body's immune system that turns genes on and off by modifying proteins called histones embedded in DNA.

Through a series of experiments in mice, Chen and his colleagues demonstrate that MYSM1 is required for natural killer cells to mature and function properly.

"We found that MYSM1 creates access to proteins that enhance gene transcription and, ultimately, the maturation of natural killer cells themselves," said Vijayalakshmi Nandakumar, a Ph.D. student at the Keck School of Medicine of USC and the study's first author. "To date, there are no elaborate reports linking an epigenetic phenomenon to natural killer cell development. More importantly, unlike conventional therapies, NK cell-based therapies have shown to be more effective against metastasis. We believe cancer drugs targeting this pathway could be a viable option for future immunotherapies."




Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Cells 
8/14/14 
★★★ 

Immune Cell Discovery Could Help to Halt Cancer Spread
By Walter and Eliza Hall Institute
Killer 
2/26/12 
How to Rescue the Immune System
By Loyola University Health System
In a study published in Nature Medicine, Loyola researchers report on a promising new technique that potentially could turn immune system killer T cells into more effective weapons against …
Cells 
10/24/11 
Unraveling the Mysteries of the Natural Killer Within Us
By Monash University
Scientists have discovered more about the intricacies of the immune system in a breakthrough that may help combat viral infections such as HIV. Co-led by Professor Jamie Rossjohn …
Cells 
8/7/12 
Why Do Infants Get Sick So Often?
By University of Michigan Health System
ANN ARBOR, Mich. – Researchers at the University of Michigan Health System are helping to quell parents' worry about why infants seem to get sick so often. It's …
Cells 
6/26/12 
UGA Study Reveals Flu-fighting Role for Well-known Immune Component
By University of Georgia
Athens, Ga. – University of Georgia scientists have discovered a new flu-fighting role for a well-known component of the immune system. Kimberly Klonowski, assistant professor of cellular biology in …
Cells 
11/28/12 
Scripps Research Institute Study Points to Potential New Therapies for Cancer And Other Diseases
By Scripps Research Institute
LA JOLLA, CA – November 27, 2012 – Researchers at The Scripps Research Institute (TRSI) are fueling the future of cancer treatment by improving a powerful tool in disease …
Helper 
1/21/13 
La Jolla Institute Identifies Molecular Switch Enabling Immune Cells to Better Fight Disease
By La Jolla Institute for Allergy and Immunology
SAN DIEGO – (January 20th, 2013) A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells …
Infection 
12/20/13 
★★ 
Young Killer Cells Protect Against Infectious Mononucleosis
By University of Zurich
More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus (EBV). Primary infection with this herpes virus as a young child is generally not linked …
Cells 
4/17/14 
★★★ 
Some Immune Cells Defend Only 1 Organ
By Washington University School of Medicine
Scientists have uncovered a new way the immune system may fight cancers and viral infections. The finding could aid efforts to use immune cells to treat illness. The …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition